- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
340B: Policy Stakeholder Perspectives
During this segment, the managed care stakeholders further discuss the 340B Drug Pricing Program. Brian Kiss, MD, suggests that some stakeholders in healthcare policy are interested in the consolidation brought about by the 340B program despite its burden on community practices and patients.
Scott Gottlieb, MD, and Ted Okon, MBA, explain that healthcare policy stakeholders are interested in the program because they consider integrated delivery systems to be the preferred model for healthcare delivery. Dr Gottlieb remarks that these stakeholders feel that consolidation can simplify the way healthcare is administered.
As a result, Dr Gottlieb adds, local healthcare monopolies are being created, which will ultimately drive up the cost of care and create additional challenges. For example, policy makers are focusing on large integrated delivery systems. However, healthcare is very localized and the dynamics of how smaller, local practices care for patients are different from those of major institutions, suggests Dr Gottlieb.
Ultimately, the current political administration wants a single payer system, says Mr Okon.
Ruxolitinib Cream Shows Long-Term Safety in AD, Potential for PN Treatment
March 8th 2025Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream (Opzelura; Incyte) in atopic dermatitis (AD), while late-breaking research highlighted its potential efficacy in prurigo nodularis (PN).
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Shaping Dermatology's Future by Increasing Access, Data, and Advocacy
March 7th 2025Thy N. Huynh, MD, FAAD, Bruce A. Brod, MHCI, MD, FAAD, and Melissa Piliang, MD, FAAD, discussed expanding access to pediatric dermatology, dermatology data aggregation, and advocacy for Medicare physician payment reform, respectively.
Read More
